RayStation 10.1

RayStation 10.1 is an advanced software system for planning, analysis, and administration of radiation therapy and medical oncology treatments, providing tools for commissioning, treatment planning, and session management. It incorporates new functionalities such as medical oncology dosing, brachytherapy (TG43), proton ocular planning, and robust planning for organ motion, all of which have been validated for accuracy and are designed to enhance treatment precision and clinical workflow.

RayStation 10.1 is a comprehensive software system designed for radiation therapy and medical oncology, enabling users to plan, analyze, and administer treatments. It features multiple applications: the main RayStation application for treatment planning, RayPhysics for commissioning treatment machines and imaging systems, RayTreat for sending plans to delivery devices and receiving treatment records, and RayCommand for treatment session management, including preparation and sending instructions to delivery devices. The system's core function is to propose treatment plans based on user input, which, after review and approval by authorized personnel, can be used to administer treatments, with configurable functionality to suit user needs. Version 10.1 introduces significant enhancements over its predecessor, RayStation 9.1, including medical oncology planning with dose calculations based on patient weight, body surface area, or flat-rate specifications. It also adds brachytherapy planning using the TG43 dose computation formalism (treating patient geometry as water), proton ocular treatment planning (modeling single scattering as double scattering), and an extension of robust planning to account for organ motion by generating deformed image sets for evaluation and planning. The treatment session management is upgraded from the RayTreat module to the new RayCommand module, which does not involve real-time interaction or emergency shutdown capabilities. These new functionalities have undergone validation for accuracy and clinical relevance, building upon the same software platform and quality system as the previous version.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the RayStation 10.1 medical oncology module handle complex chemotherapy regimens, including dose adjustments based on specific patient parameters beyond weight and BSA, and what are the safety checks for drug interactions?; What are the specific limitations of the TG43 formalism for brachytherapy dose calculation in RayStation 10.1, particularly in regions with significant tissue heterogeneity, and how are these addressed or communicated to the user?; Can the robust planning feature for organ motion in RayStation 10.1 utilize probabilistic modeling of motion or is it limited to discrete scenario-based evaluations, and how does this impact plan optimization for highly variable motion?; What is the typical time required for commissioning the RayPhysics application for a new treatment machine, especially for advanced techniques like proton ocular planning, and what level of physics support is recommended?; How does RayCommand integrate with various treatment delivery systems, and what are the mechanisms for verifying plan data integrity and delivery accuracy before and after treatment, especially when not involving real-time interaction?